7th Jan 2008 16:20
Akers Biosciences, Inc.07 January 2008 Resolution of litigation Akers Biosciences, Inc. (the "Company") The Company is pleased to announce that it has agreed terms for the full andfinal settlement of an action brought by CTS Distributing, Inc. ("CTS") againstthe Company. The settlement consists of a payment to CTS of US$50,000 and theissue of 500,000 common shares in the Company to CTS. The shares will be subjectto certain lock-in conditions for a period of 15 months from issue. Application has therefore been made to the London Stock Exchange for the newshares to be admitted to trading on AIM, which is expected to take place on 11January 2008. Following admission, the Company will have 66,592,569 voting ordinary shares inissue. Contact:Thomas A. Nicolette +1 856 848 8698President Alasdair Younie/Phillip Young +44 (0) 20 7012 2000Arbuthnot Securities Limited This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
AKR.L